Search

Belimumab Pharmacokinetic Simulations to Select an Appropriate Subcutaneous Dosing Regimen to Treat Paediatric Patients with Active Lupus Nephritis.

Therapeutic area :

Vendel E., Noort van N.,  Vis P., Liefaard L., Dimelow R. Belimumab Pharmacokinetic Simulations to Select an Appropriate Subcutaneous Dosing Regimen to Treat Paediatric Patients with Active Lupus Nephritis. PAGE 2024 [Link to publication]

Our expertise

Biologicals CNS Anti-infectives and immunology Gastrointestinal Diseases Methods Anesthesiology Cardiovascular Paediatrics Safety pharmacology Diabetes Pain Peripheral Nervous System Lung Diseases Blood disorders Oncology Endocrinology/Sexual health General modelling